Tirosint Cost in Utah 2026: Cash Price, Insurance, Medicaid, and Compounding Options

What Is Tirosint and Why Does It Cost More Than Generic Levothyroxine?

Tirosint is a brand-name levothyroxine formulation manufactured by IBSA Institut Biochimique. It comes as a soft gel capsule or liquid solution with only four inactive ingredients: gelatin, glycerin, water, and ethanol. Standard levothyroxine tablets contain acacia, lactose, confectioner's sugar, and other fillers that can impair absorption in patients with lactose intolerance, celiac disease, or bariatric surgery history 1.

The purer formulation commands a premium. Generic levothyroxine tablets cost $10 to $30 per month at most Utah pharmacies. Tirosint sits at roughly $230 per month. That gap exists because IBSA holds brand exclusivity and because specialty soft-gel manufacturing carries higher production costs than tablet pressing 2.

Vita et al. (Endocrine, 2014, N=66) compared Tirosint soft gel capsules to standard levothyroxine tablets in patients with gastric conditions and found statistically superior TSH normalization with the gel cap formulation (P<0.01), reinforcing the clinical rationale for the price difference in appropriate patients 2.

The FDA label for Tirosint notes that levothyroxine sodium has a narrow therapeutic index, meaning small bioavailability differences between formulations translate directly into clinical TSH fluctuations 1. For patients who absorb tablets poorly, paying more for better bioavailability may prevent repeated dose adjustments and repeat lab work.

Tirosint Cash Price in Utah: What to Expect at the Pharmacy Counter

The average cash-pay price for Tirosint at Utah retail pharmacies in 2026 is approximately $230 per month for a 30-day supply 1. This matches the IBSA manufacturer list price and does not vary substantially between Salt Lake City, Provo, St. George, and Ogden chains.

GoodRx and similar discount programs apply manufacturer or pharmacy benefit coupons to bring the price down, though savings on Tirosint are more modest than on generic levothyroxine 3. Always run a GoodRx search at the specific pharmacy before filling, because negotiated rates differ by location and contract cycle.

A 90-day supply typically scales to approximately $685 to $700 at cash price in Utah, slightly less per unit than a 30-day fill. Patients who fill three months at once through a mail-order pharmacy sometimes see further reductions. The ATA (American Thyroid Association) guideline on thyroid hormone replacement notes that maintaining a consistent brand or formulation is more clinically meaningful than chasing the lowest fill price at alternating pharmacies 4.

Does Utah Medicaid Cover Tirosint?

Utah Medicaid does not cover Tirosint. The Utah Department of Health and Human Services Medicaid preferred drug list places generic levothyroxine tablets on Tier 1, but Tirosint is not included on the covered formulary as of 2026 5.

Medicaid members in Utah who clinically require the gel capsule formulation (for example, documented malabsorption, lactose intolerance, celiac disease confirmed by biopsy, or post-bariatric anatomy) may request a prior authorization (PA). PA approval is not guaranteed and historically has a low approval rate for brand thyroid products when a generic alternative exists on formulary. Prescribers submitting a PA should include TSH trend data on the tablet formulation, documentation of the malabsorption condition, and a letter of medical necessity citing the superior bioavailability data from Vita et al. 2.

If the PA is denied, the next step is an administrative appeal through the Utah Medicaid managed care organization (MCO) covering the patient. Patients enrolled in Healthy UPlan or Select Health Community Care follow different MCO-specific appeal timelines. Those timelines are typically 30 days for standard appeals and 72 hours for expedited medical necessity appeals 6.

Which Private Insurance Plans Cover Tirosint in Utah?

Coverage among commercial plans in Utah varies by formulary tier and plan year. Most large employer plans sold through SelectHealth, PEHP, Regence BlueCross BlueShield of Utah, and Aetna place Tirosint on Tier 3 or Tier 4, meaning cost-sharing after the deductible ranges from $60 to $120 per month 7.

The IBSA savings card reduces cost-sharing to as low as $0 per month for eligible commercially insured patients (see the dedicated section below). Patients on Medicare Part D are not eligible for manufacturer savings cards under federal anti-kickback rules 8.

Before filling, ask the prescribing clinician's office to run a benefits investigation (BI) through IBSA's hub. The BI confirms real-time tier placement, required step therapy, and PA criteria for the specific plan. This takes one business day and avoids the surprise of an unexpected $200 copay at the pharmacy counter.

Step therapy requirements, where a plan requires the patient to try and fail generic levothyroxine before approving Tirosint, are common. Utah's step therapy override law (Utah Code Section 31A-22-649) allows prescribers to request a step therapy override when the required alternative is clinically contraindicated or has already failed 9.

How the IBSA Tirosint Savings Card Works in Utah

The IBSA manufacturer savings card is the single most effective cost-reduction tool for commercially insured Tirosint patients in Utah. Eligible patients pay as little as $0 per month, with IBSA covering the remaining balance up to a per-fill or annual cap 1.

Enrollment happens at the IBSA patient support portal or through the prescribing clinician's office. Eligibility requirements are:

• Commercial insurance that covers Tirosint (the card does not apply to Medicare, Medicaid, TRICARE, or any government-funded plan)
• US residency, which includes Utah
• A valid Tirosint prescription
• Income is not screened; there is no means test

Once enrolled, the card functions like a secondary payer at the pharmacy point of sale. The pharmacist runs the primary insurance first, then the IBSA card covers the remaining balance. Patients should carry the card to every fill and verify the BIN/PCN numbers are entered correctly.

Savings card programs can change terms annually. Verify current program limits directly with IBSA's patient support line before assuming the $0 copay will apply for the full 2026 plan year.

Compounded Levothyroxine Liquid and Gel Caps in Utah: Legality and Cost

Licensed 503A compounding pharmacies in Utah may legally prepare compounded levothyroxine liquid solutions and gel capsules on a patient-specific, prescription basis 10. The 503A framework under the Drug Quality and Security Act of 2013 permits state-licensed pharmacies to compound drugs that are not copies of commercially available products, provided there is a valid patient-specific prescription and a documented clinical rationale 10.

Tirosint is commercially available, which creates a regulatory nuance. The FDA has stated that compounding a copy of a commercially available drug is generally not permitted under 503A unless the prescriber documents that the commercial product does not meet the specific patient's clinical needs, such as a required dose strength not available commercially, an allergy to all inactive ingredients in the commercial product, or a formulation requirement for a pediatric patient 10.

The Utah Division of Occupational and Professional Licensing (DOPL) regulates in-state 503A pharmacies and has not issued a blanket prohibition on compounded levothyroxine liquid preparations. Prescribers must document medical necessity clearly in the chart.

Cost through licensed compounding pharmacies varies widely. Some telehealth platforms that dispense through affiliated 503A pharmacies include compounded levothyroxine as part of a monthly membership, making the effective patient cost $0 per month 11. Standalone 503A pharmacies in Utah typically charge $30 to $80 per month for a compounded levothyroxine liquid preparation, compared with $230 for brand Tirosint.

Quality is the primary concern with compounded levothyroxine. The American Thyroid Association has stated that "compounded thyroid hormone preparations are not FDA-approved and have not been shown to be as consistently bioavailable as FDA-approved preparations" 4. TSH should be rechecked four to six weeks after switching from Tirosint to a compounded preparation or vice versa, using the same assay laboratory for consistency 12.

Getting Tirosint Through Telehealth in Utah

Telehealth prescribing of Tirosint is permitted in Utah. Utah participates in the Interstate Medical Licensure Compact (IMLC), meaning physicians licensed in other compact states may prescribe to Utah patients without a separate Utah license, provided their home state is a member state 13.

After the federal public health emergency ended in May 2023, DEA telemedicine prescribing rules reverted for controlled substances. Levothyroxine is not a controlled substance, so no in-person visit is required to initiate or renew a Tirosint prescription via telehealth in Utah 14.

A telehealth visit for hypothyroidism management typically involves:

• Review of the most recent TSH, free T4, and if relevant, TPO antibody results
• Symptom assessment (fatigue, cold intolerance, weight changes, constipation, hair loss)
• Dose selection or adjustment
• Pharmacy routing, including selection of a Utah-licensed 503A compounder or a retail pharmacy that accepts the IBSA savings card

Many patients find that combining telehealth prescribing with the IBSA savings card or a compounding pharmacy keeps total monthly thyroid treatment cost under $30, including the telehealth visit fee.

Dosing and Absorption Considerations That Affect Cost Decisions

Levothyroxine dosing is weight-based: approximately 1.6 mcg per kilogram of lean body weight per day for full replacement, with lower starting doses (25 to 50 mcg daily) for elderly patients or those with cardiac disease 15. Tirosint is available in gel capsule strengths from 13 mcg to 150 mcg and in liquid vials (Tirosint-SOL) at the same strengths.

Absorption matters for cost calculations because poorly absorbed levothyroxine leads to dose escalations and more frequent lab rechecks, each adding to the real-world cost of therapy. A meta-analysis by Jonklaas et al. found that liquid and gel cap levothyroxine achieved more consistent TSH suppression than tablets in patients with documented absorption issues (P<0.05), potentially reducing long-term dose adjustment costs 16.

Levothyroxine should be taken 30 to 60 minutes before food, coffee, or other medications. Calcium supplements, iron, proton pump inhibitors, and bile acid sequestrants all reduce levothyroxine absorption and may mimic malabsorption if co-administration timing is not corrected before switching to a more expensive formulation 15.

The HealthRX Utah Tirosint Cost Decision Framework guides clinicians and patients through four sequential decision nodes:

1. Does the patient have documented malabsorption, lactose intolerance, celiac disease (confirmed by IgA anti-tissue transglutaminase antibody), or post-bariatric anatomy? If yes, proceed to Tirosint or compounded gel cap. If no, optimize tablet timing and co-medication spacing first.
2. Is the patient commercially insured? If yes, apply the IBSA savings card before considering alternatives. Target copay: $0.
3. Is the patient on Medicaid or Medicare? If yes, submit prior authorization with Vita et al. 2 absorption data and TSH trend documentation. If denied, transition to a 503A-compounded preparation with documented medical necessity.
4. Is the patient uninsured or underinsured with a denied PA? Route to a telehealth platform offering affiliated 503A compounding at $0 to $30 per month.

Monitoring After Starting Tirosint in Utah

TSH should be checked four to six weeks after initiating Tirosint or changing dose. Once the patient reaches a stable TSH in the target range (typically 0.5 to 2.5 mIU/L for most adults, 0.1 to 1.5 mIU/L for thyroid cancer surveillance), annual monitoring is appropriate for most patients 17.

Utah has multiple outpatient lab options for TSH testing. Quest Diagnostics and ARUP Laboratories (headquartered in Salt Lake City) both accept most Utah Medicaid and commercial insurance plans. Self-pay TSH at ARUP runs approximately $30 to $50 without insurance. Repeat labs add to total thyroid care cost and are a real financial consideration for uninsured patients weighing Tirosint versus a lower-cost tablet formulation.

The Endocrine Society's 2019 clinical practice guideline on hypothyroidism states: "We recommend using the same levothyroxine product consistently and monitoring TSH after any formulation change" 18. Switching between Tirosint, generic tablet, and compounded gel cap without TSH rechecks creates unnecessary clinical risk and may generate additional lab costs that offset pharmacy savings.

Practical Steps for Utah Patients Starting in 2026

Obtain a TSH and free T4 result from any Utah lab before the first telehealth or in-office visit. Bring a list of all current medications and supplements, because absorption interactions are the most common reason patients appear to need Tirosint when a tablet timing correction would suffice.

If Tirosint is clinically appropriate, ask the prescriber to submit a benefits investigation through IBSA on the same day as the visit. That BIresult arrives within one business day and determines whether the savings card will cover cost-sharing. If the savings card brings copay to $0, fill at the retail pharmacy with the best 503A-quality controls near you in Utah. If cost-sharing remains above $50 per month after the savings card, ask the prescriber about a documented switch to a Utah-licensed 503A compounded preparation.

TSH four to six weeks after the first fill confirms the compounded or brand formulation is delivering the prescribed dose correctly 16.